Understanding the long-term costs and benefits of bariatric surgery for obesity
Long-term Costs and Return on Investment for Bariatric Surgery
This study looks at how bariatric surgery, the best option for treating severe obesity, affects costs over time and how it can improve health issues like type 2 diabetes, while also exploring what stops people from getting the surgery, so we can help more folks get the coverage they need.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10597046 on NIH RePORTER |
What this research studies
This research investigates the economic impact of bariatric surgery, which is the most effective treatment for severe obesity. It aims to analyze the long-term costs associated with the surgery and its return on investment, particularly in relation to improvements in health conditions like type 2 diabetes. The study will explore barriers to surgery uptake, including patient and physician attitudes, insurance coverage, and the financial implications of complications. By gathering and analyzing data, the research seeks to provide evidence that could encourage broader insurance coverage for bariatric procedures.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are eligible for bariatric surgery due to severe obesity.
Not a fit: Patients who are not eligible for bariatric surgery or those who do not have severe obesity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased access to bariatric surgery for eligible patients, resulting in better health outcomes and reduced healthcare costs.
How similar studies have performed: Previous research has shown that bariatric surgery is effective in improving health outcomes for obesity-related conditions, indicating that this approach has a solid foundation of evidence.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Maciejewski, Matthew L — Duke University
- Study coordinator: Maciejewski, Matthew L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.